168 related articles for article (PubMed ID: 17591779)
1. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
2. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
3. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.
Lai YJ; Chen CS; Lin WC; Lin FT
Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003
[TBL] [Abstract][Full Text] [Related]
4. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT
Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301
[TBL] [Abstract][Full Text] [Related]
5. c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.
McMichael BK; Meyer SM; Lee BS
J Biol Chem; 2010 Aug; 285(34):26641-51. PubMed ID: 20547766
[TBL] [Abstract][Full Text] [Related]
6. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
Lin VT; Lin FT
Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
E S; Lai YJ; Tsukahara R; Chen CS; Fujiwara Y; Yue J; Yu JH; Guo H; Kihara A; Tigyi G; Lin FT
J Biol Chem; 2009 May; 284(21):14558-71. PubMed ID: 19293149
[TBL] [Abstract][Full Text] [Related]
8. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
9. The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.
Cuppen E; van Ham M; Wansink DG; de Leeuw A; Wieringa B; Hendriks W
Eur J Cell Biol; 2000 Apr; 79(4):283-93. PubMed ID: 10826496
[TBL] [Abstract][Full Text] [Related]
10. Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization.
Lv K; Chen L; Li Y; Li Z; Zheng P; Liu Y; Chen J; Teng J
J Neurosci; 2015 Feb; 35(6):2559-71. PubMed ID: 25673849
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
12. Supervillin modulation of focal adhesions involving TRIP6/ZRP-1.
Takizawa N; Smith TC; Nebl T; Crowley JL; Palmieri SJ; Lifshitz LM; Ehrhardt AG; Hoffman LM; Beckerle MC; Luna EJ
J Cell Biol; 2006 Jul; 174(3):447-58. PubMed ID: 16880273
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
[TBL] [Abstract][Full Text] [Related]
14. Members of the Zyxin family of LIM proteins interact with members of the p130Cas family of signal transducers.
Yi J; Kloeker S; Jensen CC; Bockholt S; Honda H; Hirai H; Beckerle MC
J Biol Chem; 2002 Mar; 277(11):9580-9. PubMed ID: 11782456
[TBL] [Abstract][Full Text] [Related]
15. LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor.
Zhao MK; Wang Y; Murphy K; Yi J; Beckerle MC; Gilmore TD
Gene Expr; 1999; 8(4):207-17. PubMed ID: 10794523
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.
Kimber WA; Deak M; Prescott AR; Alessi DR
Biochem J; 2003 Dec; 376(Pt 2):525-35. PubMed ID: 14516276
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
Villa F; Deak M; Bloomberg GB; Alessi DR; van Aalten DM
J Biol Chem; 2005 Mar; 280(9):8180-7. PubMed ID: 15611135
[TBL] [Abstract][Full Text] [Related]
18. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
Chastre E; Abdessamad M; Kruglov A; Bruyneel E; Bracke M; Di Gioia Y; Beckerle MC; van Roy F; Kotelevets L
FASEB J; 2009 Mar; 23(3):916-28. PubMed ID: 19017743
[TBL] [Abstract][Full Text] [Related]
19. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
Bompard G; Puech C; Prébois C; Vignon F; Freiss G
J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
[TBL] [Abstract][Full Text] [Related]
20. TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation.
Lin FT; Lin VY; Lin VT; Lin WC
Cell Discov; 2016; 2():15048-. PubMed ID: 27134758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
